Microscope

OUR STORY

CUPROUS Pharmaceuticals Inc. (CPI) is a Canadian biotech company that spun out from BC Cancer. The inspiration for CPI came from an interest in developing copper-activated drugs to treat aggressive cancers that are resistant to standard of care therapeutics. Metal complexes in general, exhibit therapeutic potential when used to treat a plethora of clinical conditions including, bacterial infections, inflammatory diseases, neurodegenerative diseases and cancers. Despite the therapeutic potential of metal complexes, there is a dearth of this class of drugs available for human use. The large gap between the chemistry creating these promising drug candidates and their pre-clinical and clinical development has been addressed through use of CPI’s platform Metaplex technology. Metaplex enables the development of pharmaceutically viable formulations of metal-binding small molecules. CPI is excited to co-develop best-in-class small molecule nanomedicines with partner industrial and academic/research institutions to address unmet medical needs.

 

THE CUPROUS TEAM

Tom Redelmeier.png

THOMAS REDELMEIER, PHD

Founder, CEO & President

Mike Abrams (linkedin).jpg

MICHAEL ABRAMS, PHD

Vice President, Research

Marcel Bally_cropped.png

MARCEL BALLY, PHD

Founder, Chief Scientific Officer

AACR PLOS ii 055.jpg

ADA LEUNG, PHD

Founder, Director of Operations

 

OPEN POSITIONS

We are looking for self-motivated talents to join our team. CPI embraces diversity and is an equal-opportunity employer.

RESEARCH ASSOCIATE

Full Time

BUSINESS DEVELOPMENT SPECIALIST

Full Time

 

Address

2405 Wesbrook Mall
Vancouver BC V6T 1Z3

Contact

Follow

©2019 by Cuprous Pharmaceuticals.